| Literature DB >> 26231186 |
Eran Bashan1, Roy Harper2, Yixi Bi3, Israel Hodish4.
Abstract
Insulin therapy has been available for almost a century. However, its success rate is still disappointing where the majority of users sustain harmfully elevated glycated haemoglobin (HbA1c) levels. The key element essential for effective and safe insulin therapy is frequent dosage titration to overcome constant variations in insulin requirements. In reality, dosage titration is done sporadically during clinic visits. A scalable solution to this problem is being reviewed. A diabetes nurses service improves glycaemic control without overburdening the health system. The service relies on a handheld device, which provides patients with an insulin dose recommendation for each injection while using the device to monitor glucose. Similar to the approach providers use during clinical encounters, the device analyses stored glucose trends and constantly titrates insulin dosage without care providers' supervision. In this report, we describe the logic behind the technology by providing examples from users. 2015 BMJ Publishing Group Ltd.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26231186 PMCID: PMC4521526 DOI: 10.1136/bcr-2015-209356
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X